Hongcheng Lu
- Topics
- Ferroptosis and cancer prognosis (8 papers)Cancer-related molecular mechanisms research (8 papers)RNA modifications and cancer (7 papers)
- Journals
- PLoS ONEOncogeneThe FASEB Journal
- Partner nations
- ChinaUnited States
In The Last Decade
Hongcheng Lu
28 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 994
- Cancer Research 675
- Pulmonary and Respiratory Medicine 184
- Oncology 162
- Surgery 96
Countries citing papers authored by Hongcheng Lu
This map shows the geographic impact of Hongcheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongcheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongcheng Lu more than expected).
Fields of papers citing papers by Hongcheng Lu
This network shows the impact of papers produced by Hongcheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongcheng Lu. The network helps show where Hongcheng Lu may publish in the future.
Co-authorship network of co-authors of Hongcheng Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongcheng Lu. A scholar is included among the top collaborators of Hongcheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongcheng Lu. Hongcheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 18 | |
| 6 | 8 | |
| 7 | 9 | |
| 8 | 8 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 11 | |
| 12 | 12 | |
| 13 | 55 | |
| 14 | 3 | |
| 15 | 2 | |
| 16 | 98 | |
| 17 | The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancerbreakdown → | 205 |
| 18 | METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent mannerbreakdown → | 546 |
| 19 | 26 | |
| 20 | 0 |
About Hongcheng Lu
Hongcheng Lu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (675 citations), Molecular Biology (994 citations) and Oncology (162 citations). Hongcheng Lu has collaborated with scholars based in China and United States. Frequent co-authors include Jie Han, Qiang Lü, Haiwei Yang, Xiao Yang, Ji‐Fu Wei, Hao Yu, Wenbo Yuan, Rui Zhou, Zijian Zhou and Sheng Zhou. Their work appears in journals such as PLoS ONE, Oncogene and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.